chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the vaccine, her subsequent period was anything but normal.; A cycle lasting twice as long and heavy with blood clots is not a fluke.; After receiving the first dose, we are going to delay the second dose until more data is collected; This is a spontaneous report from a contactable other HCP. A 14-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, Batch/Lot Number: Was not reported), via an unspecified route of administration on an unspecified date (14-years-old at the time of vaccination), as a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced after receiving the vaccine, her subsequent period was anything but normal, a cycle lasting twice as long and heavy with blood clots is not a fluke, and after receiving the first dose, we are going to delay the second dose until more data is collected. The outcome of all the events was unknown.  Information about lot/batch number has been requested.
Paroxysmal atrial fibrillation - Patient stable overnight. EP was consulted and stress test was ordered without any ischemia. He was sent home with metoprolol. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Patient started to experience pain at the site of injection approximately two hours after the immunization. She said now 4 weeks later her arm hurts when she moves it up or around.
Rph administered a Covid  shot to a 17 years old . The patient looked much older for his age .
Have had upper and lower gastrointestinal distress, nausea, persistent diarrhea since Nov. 2002. All Dx studies WNL. Neg. upper GI, Abd. Ct., EGD, Colonoscopy, Blood work normal diarrhea loose stools continue daily.
Received the first dose of Moderna on 3/19/21 am.   At approximately 3 pm, my right side went numb.  Traveling at the time, we arrived at 4:30 pm and it seemed to have subsided.  Waited until the next morning and went to the hospital  because the symptoms came back.  They did a CAT scan and confirmed I had a stroke.  I was flown to another hospital where several tests were performed including MRI etc.  and confirmed again that it was a stroke.   Was released the following day with medication prescribed by doctors.  The fact that I had gotten my first vaccine that morning, was brought up multiple times and was  side stepped.  They told me it wasn't likely that the vaccine is what caused it, but would not rule it out.  No doctors up until today when I had follow up appt, have told me to report this event.
Patient was having perspiration and tightness in the chest, eventually began to have numbness and tingling in the throat and face
p/ pt recv vax 1/98 in 3/98 the pt exp breakthrough varicella
pt had a hosp admission in January 2022 for CHF exacerbation, HTN, mild AKI, and positive for COVID; on 2/3/22 pt admitted to hospital with sciatica type lower back pain; given dexamethasone to improve back sx; worsening AKI; pt had a drop in hemoglobin after a melanotic stool; EGD done; pt intubated; found duodenal ulcer; pt's condition worsened; experienced asystole; ACLS protocol CPR x 3 rounds with meds, ROSC achieved; metabolic status worsened; pt was made comfort care and passed away in the hospital; DC and med records sent to info@vaers.org
Consistently drenched in sweat for 48 hours after vaccine. Had mucus like substance seeping from anus twice in first 48 hours. Almost like diarrhea except no sense of urgency to go or stomach cramps. Just all of sudden realized  my underwear wear wet. Went to restroom and saw small amount of mucus like substance.
01/01/22 presents to EC ED for "rectal bleeding and b/l leg swelling for 10 days". PMHx of "HTN, dementia AOX1 at baseline"
Janssen COVID vaccine received on 3/9/2021 She was at hospital for chemo treatment on 7/19/2021 and tested positive for COVID-19 tested due to shortness of breath Hospitalized on 7/26/2021 with trace of left pleural effusion
COVID-19 Vaccine Moderna Lot #027B21A Patient received 1st dose of Moderna COVID-19 Vaccine @ 1324. At 1330 during the observation period patient was found to be unconscious in his chair. Patient was immediately aroused and assessed. Patient Vital signs were within normal limits and patient noted to be diaphoretic. Patient did not recall  loss of consciousness and only recalled the period before the event and then immediately after when aroused. Patient had no signs of allergic reaction. patient did state he felt anxious before recieving his vaccine. Patient assessed to have had a vasovagal response and transferred by EMS to ED for further evaluation.
Patient is reporting a sore arm as of 11/2/16 (19 days post-injection). Was not accurate/consistent rating it on a pain scale of 1-10. Did not report that he still has a lump or induration at injection site, just pain - especially upon elevation of the arm.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
I started getting symptoms of scratchy throat, runny nose, cough, general malaise. The next day, I took an at home COVID-19 test that was positive. I was prescribed Molnupiravir on 5/16/2022 by my doctor which has seemed to help my symptoms. I feel better today and my voice is back.
DTaP, IPV, Hib given on 11/19/03. Mom called evening of 11/20/03 to report unusual pattern of gasping respiration lasting approximately 2 hrs no fever (+) lethargy resolved spontaneously but recurred on 11/23/03-event to ER. FSWU done and admitted. The hospital discharge summary received on 01/02/04 states altered mental state, urinary tract infection and metabolic acidosis.
Large firm, red region at site of injection. Skin is itchy but not painful. Estimate 3 inch in diameter. Will treat with warm compress anti inflammatory.
Patient reported nausea, blurred vision, and shakiness 20 mins after the shot. She called and asked if that was normal. I told her it wasnt unheard of but that she should go to an urgent care clinic to be safe. She called after being released from the clinic and was told she was going to be ok and that her reaction was normal after a shot.
Very shortly after receiving the vaccine the patient's head dropped down and she momentarily fainted. She was held in her seat so that she didn't fall out and was awakened only seconds later. She was kept in her seat for 15 minutes after the incident until she felt stabilized. She stood up slowly and assessed for balance and strength. She and her father felt she was stable enough to go home.
Received Tdap (L deltoid) on floor where she works (10NW)on 11/07. 11/08 got swelling, heat to L area and developed fever. Seen in OHS on 11/09 with 10cm area of erythema with +epitrochler node to left arm. + swelling of left wrist. No numbness, +radial pulse and CSM.
Female  presenting with pain and swelling to the right lower extremity that occurred 2 months ago. Symptoms occurred gradually and are still present. Symptoms are described as moderate in nature.  Patient states that her symptoms began after receiving the first dose of a COVID-19 vaccine.  Patient is also complaining of a left-sided headache that has been ongoing for the past 2 weeks.  She states that the pain also radiates into her neck and she endorses dizziness.  She states that ibuprofen helps mildly.  Patient also complains of right shoulder pain.  She states that she has been to see her primary care doctor for the symptoms and was told that her leg was an infection.
Neuropathy, needles and pain at touch: left side of face went numb for a few days after vaccine. Limbs would randomly go numb as well
On 01/2023 'I've  noticed  that both of my legs swelled up.  I also lost balance so I started seeing a physical therapist from 03/02/2023.  They prescribed Bumex for 60 days. It helped for awhile. The swelling of the legs went away eventually. I also took a Pneumonia vaccine on the same day so may be it could be from there am not sure.  Am also taking my regular medication Lasix for swelling.
This is a spontaneous case, initially received from other non-health professional on 26-Oct-2018, concerning a female patient of an unspecified age. It was reported that whenever flu vaccine was drawn up, it leaked out from the rubber stopper. One of the nurses noticed when they popped the secured lock off the vial the rubber stopper was dented in and off a little. The nurses advised when they removed the hard cap and stuck the needle in the middle, there was a corner of the top where the rubber stopper was dented in causing a hole where the medication would leak. About 5 doses were drawn out of 10 doses in the vial. The vials leaked and only 4 vials were leaking so far. On 05-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252234 and expiry date: 30-Jun-2019] from the leaking vial. No adverse events were reported after administration of the vaccine. This case is linked to 201804823, due to the same reporter. This case was associated with product quality complaint, hence quality assurance investigation (QAI) had been requested and the corresponding PTC reference number was 1034101. Based on the QA investigation report, it was concluded that FLUCELVAX Batch 252234 was manufactured in compliance with the approved internal procedures and in accordance with the quality requirements. No internal root cause was identified in the manufacturing process. A known trend was identified for the FLUCELVAX batches from the 2018/2019 FLUCELVAX commercial season for vials leaking at the stopper during dosing. A review revealed that the complainant was adding air to the vial prior to extracting doses and was inverting the vial when withdrawing the needle from the stopper. It is known that the addition of air to the vial can over pressurize the vail and cause leaking. In addition, inverting the vial while trying to extract a dosage can increase potential for the vial to leak. The root cause for this investigation was found to be user-improper handling. The reporter assessed this case as non-serious. Follow-up report received from QA department on 19-Nov-2018: The QA investigation report stated that, the root cause for the leaking FLUCELVAX MDV of Batch 252234 was due to user or improper handling. Added new event (wrong technique in product usage process) in event tab. The narrative and the case comment were amended accordingly.
pain in the arm; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Cold sore; Tinnitus-bilateral; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 18:00 (at the age of 40-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included sarcoidosis and Premature Ventricular Contractions (PVCs). Concomitant medications included verapamil (MANUFACTURER UNKNOWN). The patient previously took atenolol (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, after first dose of vaccination, the patient had bilateral tinnitus and cold sore broke out. On 28Apr2021 at 04:00, after second dose of vaccination, the patient had bilateral tinnitus and cold sore broke out. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of bilateral tinnitus and cold sore which included treatment with prednisone and a hearing test. The clinical outcome of the event bilateral tinnitus and cold sore was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
patient received booster shot on 12/22/21.  then had a stroke on 1/1/22.  he is still hospitalized and now on a feeding tube
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a 24-month-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 19-Feb-2012. On 21-Feb-2012, the patient received expired FLUMIST. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments are not applicable, and the events its considered resolved. This case will be submitted in accordance with MedImmune FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
Within 24 hours Weakness (Jelly like) muscles in limbs, numbness, tingling, twitching, burning, brain fog. Within a few hours of vaccine high fever, chills, body aches, head ache.
Patient was given 0.25mcg Moderna Bivalent Booster, was to be given 0.5mcg. Wrong dose was given to patient.
Neck and headache, chill, diaphoresis, flank pain, chest pain. Symptoms last every night. Mild headache now.
Pt recvd 3 doses of Engerix-B 6MAY91, 3JUN91, & 11NOV91 & 11NOV91 immed following 3rd inject pt exp burning while inject was being given;
Oct 10, 2013 Fri. 2 days after Flu shot woke up with slight swelling around both eyes and lower back. Sat. morning woke with right eye watering/itchy and swollen shut, restrictive breathing and lower back inflamed. Took antihistamine to relieve symptoms. Next 2 days reduced swelling around eyes, but lower back feels like kidneys are bruised.
Headache, body aches, sore arm, fatigue beginning about 9 hours after vaccine.
C/o feeling hot flush heart rate 104. Denies no  dizziness, nausea, chest pain, or SOB. EMS evaluated P 94 148/99.   Ok to walk with husband as nd left for home w husband 12:26 pm.
Abdominal pain and chills two days after second vaccine which led to orchitis and 4 days in the hospital
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.      In 2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX), (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. Subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the patient experienced shingles (date unspecified) and was treated by a healthcare provider and was hospitalized due to the event (date unspecified).  As a direct and proximate result of patient use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was considered as not resolved. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Narrative: Patient is an 80-year-old female who received the COVID-19 vaccination (Moderna) on 1/22/22. She reported experiencing pain at the injection site and difficulty raising the injected arm to her primary care provider. She also reported fatigue, nausea, abdominal cramping, and loose stools. She did not seek any medical treatment for these conditions, and symptoms were self-limited.
pt presents to the hospital with SOB "for a few weeks"; saw PCP and received steroids and doxycycline; no improvement; to ED; found to be positive for COVID; given O2 supplementation; steroids; DNR; pt in hospital from 1/13/22 - 2/6/22; pt dc'd to home with hospice (name of organization not in medical records) where she passed away
I continue to struggle with these re-awakened symptoms from my Covid infection 11/2020  * Headaches * Spiking blood pressure * Brain fog/light headedness * I often smell a campfire, i.e. wood burning smell
Swelling and redness 3 1/2 " at injection site tender to touch dx cellulitis treated w/ AUGMENTIN.
Mom reports (R) leg sl. swollen, non-tender at site of vaccine. Denies lg. hardened area, child is afebrile and acting fine. Gave Mom S/S of sterile abscess and cellulitis. She will observe and call with concerns or questions.
The patient reported developing hives the same day as her vaccination. She sought care at an emergency room for the hives. The hives lasted for three days.
Mom called to report that the patient was hard to arouse this am, was more sleepy.  Advised mom to take patient to his primary care provider.
Employee states that she received Dose #2 the day after the end of her menstrual cycle and that she began bleeding again after receiving her second dose and that it was a heavy and clotted cycle.  She was advised to contact her OB/GYN
In the afternoon after receiving yellow fever injection, patient developed redness, swelling, & itching at site in left arm. Reports feeling tired & nauseous last weekend. 1 week later, reports soreness & mild itching. Did not apply ice or heat or take any analgesic.
Information has been received from a physician concerning a 73 year old female who in approximately September 2008, "about a month ago", was vaccinated with ZOSTAVAX (Lot# was not available, therapy route, site unknown). Subsequently the patient developed rash on injection site on her right arm. The patient sought medical attention. The patient's outcome was unknown. Additional information has been requested.
5/9/07 pt had lymphadenitis and streaking s/p smallpox on 4/30/07; 5/11/07 pt developed chest pain and admitted to civilian hospital with pericarditis.  9/4/07 Reviewed medical records from WRAMC-VHC which reveal  patient experienced swelling, redness, streaking & lymph node swelling 7-9 days s/p vax on 4/30 then developed chest pain 5/8/07 which progressed & was admitted to outlying hospital 5/11-5/12/07.   FINAL DX: Pericarditis.
Redness/swelling of upper, outer left thigh (inj. site). Given RX of KEFLEX and notified to take OTC BENADRYL.
Moderna 4/16/21 & 5/14/21 Presented to the ED with weakness and SOB, symptoms started 4 days prior (1/16/22).  Pt has poor oral intake and increasing weakness, generalized body aches - no fevers.  Upon arrival to the emergency department, patient was found to have acute hypoxemic respiratory failure secondary to sepsis in the setting of COVID-19 pneumonia.  Accelerated hypertension was also noted.  Initial lab work consistent with leukocytosis 11.6, thrombocytosis 526, elevated INR 2.0, hypokalemia 2.9, hypochloremia 97, hyperglycemia 125, hypoalbuminemia of 3.1, and transaminitis.  Initial lactic acid 1.5.  Initial troponin 42.  EKG independently reviewed and consistent with paced rhythm.  Chest x-ray also independently reviewed and consistent with bilateral infiltrates.  Patient tested positive for COVID-19. Patient discharged 1/24/22.
first dose /on Dec-10-2020; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 10th December 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. No other information about the patient was provided. Pharmacist declined to give adverse event information because he was busy. The reporter consented to follow up.
Pt reports pain in right arm pt that spread to right breast then to left breast. Pt is unsure if vaccine is the cause, but pain has not subsided.
Menstrual events have been different. For as long as I have had my period, 13 years, I have been very consistent, same flow, same symptoms, etc. since having my first dose of the vaccine, I have had 2 periods. One was very heavy and painful with lots of clots (which I have never experienced) and this current one, I had one day of a small amount of blood and cramps. This is not normal for me at all.
24 hrs after getting my 2nd dose of the Moderna vaccine, woke up next morning feeling feverish, body aches, headache, chills and muscle pain.  Symptoms prolong through out the day into all night till the next following day. Symptoms started to subside by noon and by evening.